{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:09:03Z","timestamp":1790179743685,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["USAID\\u2019s Alliance for Combating TB in Bangladesh activity (ACTB)"],"award-info":[{"award-number":["USAID\\u2019s Alliance for Combating TB in Bangladesh activity (ACTB)"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jgar.2026.07.015","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:04:15Z","timestamp":1785283455000},"page":"364-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discordant rifampicin resistance results in repeat Xpert MTB\/RIF testing: Risk factors and diagnostic challenges among drug-resistant tuberculosis patients in Bangladesh"],"prefix":"10.1016","volume":"50","author":[{"given":"Mohammad Khaja Mafij","family":"Uddin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumana","family":"Nasrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannatul","family":"Ferdous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar Faruk","family":"Bhuiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1582-6262","authenticated-orcid":false,"given":"Tanjina","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Shirajul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawon","family":"Barua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Saidul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Shamim","family":"Ahammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Mahabubur Rahaman","family":"Fuad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fardaus Ara","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Mohammad Mazidur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8833-4130","authenticated-orcid":false,"given":"Shahriar","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aung Kya Jai","family":"Maug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayera","family":"Banu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2026.07.015_bib0001","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1183\/09031936.05.00111304","article-title":"Drug-susceptibility testing in tuberculosis: methods and reliability of results","volume":"25","author":"Kim","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jgar.2026.07.015_bib0002","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s12879-016-1745-2","article-title":"Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB\/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study","volume":"16","author":"Ullah","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2026.07.015_bib0003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jctube.2018.04.002","article-title":"The value of Xpert MTB\/RIF-generated CT values for predicting the smear status of patients with pulmonary tuberculosis","volume":"13","author":"Fradejas","year":"2018","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.jgar.2026.07.015_bib0004","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.diagmicrobio.2016.01.009","article-title":"False-positive rifampin resistant results with Xpert MTB\/RIF version 4 assay in clinical samples with a low bacterial load","volume":"85","author":"Ocheretina","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2026.07.015_bib0005","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5588\/ijtld.11.0395","article-title":"False-positive rifampicin resistance on Xpert\u00ae MTB\/RIF: case report and clinical implications [Technical note]","volume":"16","author":"Van Rie","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jgar.2026.07.015_bib0006","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01696-17","article-title":"False-positive Xpert MTB\/RIF results in retested patients with previous tuberculosis: frequency, profile, and prospective clinical outcomes","volume":"56","author":"Theron","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2026.07.015_bib0007","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.5588\/ijtld.17.0792","article-title":"Discordance in Xpert\u00ae MTB\/RIF assay results among low bacterial load clinical specimens in Bangladesh","volume":"22","author":"Sahrin","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jgar.2026.07.015_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01599-17","article-title":"Role of disputed mutations in the rpoB gene in interpretation of automated liquid MGIT culture results for rifampin susceptibility testing of Mycobacterium tuberculosis","volume":"56","author":"Miotto","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2026.07.015_bib0009","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.5588\/ijtld.14.0297","article-title":"False-positive rifampicin resistance on Xpert(R) MTB\/RIF caused by a silent mutation in the rpoB gene","volume":"18","author":"Mathys","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jgar.2026.07.015_bib0010","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/jac\/dkq519","article-title":"Mutations outside the rifampicin resistance-determining region associated with rifampicin resistance in Mycobacterium tuberculosis","volume":"66","author":"Siu","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2026.07.015_bib0011","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1183\/09031936.00089808","article-title":"Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan","volume":"33","author":"Hofmann-Thiel","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jgar.2026.07.015_bib0012","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5588\/ijtld.17.0837","article-title":"Discordant rifampicin susceptibility results are associated with Xpert((R)) MTB\/RIF probe B and probe binding delay","volume":"23","author":"Berhanu","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jgar.2026.07.015_bib0013","unstructured":"World Health Organization Global tuberculosis report 2025:2025. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/e97dd6f4-b567-4396-8680-717bac6869a9\/content."},{"key":"10.1016\/j.jgar.2026.07.015_bib0014","series-title":"Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB","year":"2013"},{"key":"10.1016\/j.jgar.2026.07.015_bib0015","first-page":"775","article-title":"Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria","volume":"87","author":"Kubica","year":"1963","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jgar.2026.07.015_bib0016","first-page":"21","article-title":"Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes","volume":"41","author":"Canetti","year":"1969","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jgar.2026.07.015_bib0017","unstructured":"National TB Control Programme Manual of Standard Operating Procedures (SOPs), Culture of Mycobacterium tuberculosis and drug susceptibility testing on solid medium. https:\/\/www.ntp.gov.bd\/wp-content\/uploads\/2024\/06\/SOP_MTB-Culture_DST.pdf."},{"key":"10.1016\/j.jgar.2026.07.015_bib0018","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ijmyco.2016.06.005","article-title":"Evaluation of the GenoType MTBDRplus assay for detection of rifampicin-and isoniazid-resistant Mycobacterium tuberculosis isolates in central Ethiopia","volume":"5","author":"Omer","year":"2016","journal-title":"Int J Mycobacteriol"},{"key":"10.1016\/j.jgar.2026.07.015_bib0019","unstructured":"GenoType MTBDRplus VER, Use H Lifescience. Editor. https:\/\/www.hain-lifescience.de\/."},{"key":"10.1016\/j.jgar.2026.07.015_bib0020","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S1473-3099(18)30496-1","article-title":"Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study","volume":"18","author":"Makhado","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2026.07.015_bib0021","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02338-2020","article-title":"Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs","volume":"57","author":"Jouet","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jgar.2026.07.015_bib0022","first-page":"1070","article-title":"Tuberculosis diagnosis\u2014Time for a game change","volume":"363","author":"Small","year":"2010","journal-title":"Mass Med Soc"},{"key":"10.1016\/j.jgar.2026.07.015_bib0023","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/S2666-5247(20)30007-0","article-title":"Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB\/RIF results: a prospective observational study in Rwanda","volume":"1","author":"Ngabonziza","year":"2020","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jgar.2026.07.015_bib0024","doi-asserted-by":"crossref","first-page":"881","DOI":"10.5588\/ijtld.21.0564","article-title":"Impact of the bacillary load on the accuracy of rifampicin resistance results by Xpert\u00ae MTB\/RIF","volume":"25","author":"Ocheretina","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jgar.2026.07.015_bib0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/bbrj.bbrj_6_17","article-title":"Predictable repeatability issues with GeneXpert-Xpert MTB\/RIF (version 4) derived rifampicin resistant tuberculosis results from South India: appreciating the limits of a technological marvel! biomedical and","volume":"1","author":"Sanker","year":"2017","journal-title":"Biotechnol Res J (BBRJ)"},{"key":"10.1016\/j.jgar.2026.07.015_bib0026","article-title":"Factors influencing false-positive results of rifampicin resistance detected by Xpert MTB\/RIF: a retrospective study in Zhejiang","volume":"10","author":"Wu","year":"2024","journal-title":"China Heliyon"},{"key":"10.1016\/j.jgar.2026.07.015_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089301","article-title":"Feasibility of decentralised deployment of Xpert MTB\/RIF test at lower level of health system in India","volume":"9","author":"Raizada","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2026.07.015_bib0028","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab034","article-title":"Low cycle threshold value in Xpert MTB\/RIF assay may herald false detection of tuberculosis and rifampicin resistance: a study of two cases","author":"Ngabonziza","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2026.07.015_bib0029","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/jac\/dkz564","article-title":"Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impact","volume":"75","author":"Van Rie","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2026.07.015_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152694","article-title":"Comparison of Xpert MTB\/RIF assay and GenoType MTBDR plus DNA probes for detection of mutations associated with rifampicin resistance in Mycobacterium tuberculosis","volume":"11","author":"Rahman","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2026.07.015_bib0031","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/JCM.00434-12","article-title":"Mixed tuberculosis infections in rural South Vietnam","volume":"50","author":"Huyen","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2026.07.015_bib0032","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1128\/JCM.01378-10","article-title":"Mixed-strain Mycobacterium tuberculosis infections among patients dying in a hospital in KwaZulu-Natal, South Africa","volume":"49","author":"Cohen","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2026.07.015_bib0033","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1128\/CMR.00021-12","article-title":"Mixed-strain Mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control","volume":"25","author":"Cohen","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2026.07.015_bib0034","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1128\/JCM.00128-10","article-title":"Evaluation of the analytical performance of the Xpert MTB\/RIF assay","volume":"48","author":"Blakemore","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2026.07.015_bib0035","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1128\/JCM.00143-12","article-title":"Rapid, high-throughput detection of rifampin resistance and heteroresistance in Mycobacterium tuberculosis by use of sloppy molecular beacon melting temperature coding","volume":"50","author":"Chakravorty","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2026.07.015_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(20)30123-3","article-title":"Management of false-positive rifampicin resistant Xpert MTB\/RIF","volume":"1","author":"Beylis","year":"2020","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jgar.2026.07.015_bib0037","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/S2666-5247(20)30007-0","article-title":"Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB\/RIF results: a prospective observational study in Rwanda","volume":"1","author":"Ngabonziza","year":"2020","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jgar.2026.07.015_bib0038","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00812-17","article-title":"The new Xpert MTB\/RIF Ultra: improving detection of Mycobacterium tuberculosis and resistance to Rifampin in an assay suitable for point-of-care testing","volume":"8","author":"Chakravorty","year":"2017","journal-title":"mBio"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526001268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526001268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:50:58Z","timestamp":1790178658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716526001268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":38,"alternative-id":["S2213716526001268"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2026.07.015","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discordant rifampicin resistance results in repeat Xpert MTB\/RIF testing: Risk factors and diagnostic challenges among drug-resistant tuberculosis patients in Bangladesh","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2026.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}